Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 50 New Entrants companies in Monoclonal antibody
by Most Patent Filing In 5 Years in the China in 2022

The Monoclonal antibody top 50 is Discovery PatSnap’ annual ranking of the top 50 Most Patent Filing In 5 Years Monoclonal antibody New Entrants in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
Patent: 46
2
Patent: 27
3
Patent: 21
4
Patent: 14
5
Patent: 13
6
Nanjing Leads Biolabs Co. Ltd.
Patent: 12
7
Patent: 12
8
Patent: 12
9
Patent: 10
10
Patent: 9
11
Health care,Immunotherapy,Drug
Patent: 9
12
Patent: 8
13
Jiangsu Huaiyu Pharmaceutical Co Ltd
Patent: 8
14
Patent: 7
15
Patent: 7
16
Patent: 7
17
Patent: 7
18
Patent: 6
19
Patent: 6
20
Patent: 6
21
Patent: 6
22
Fuzhou Tcelltech Biological Science and Technology Inc.
Patent: 5
23
Patent: 5
24
Hunan Qiankang Technology Co., Ltd.
Patent: 5
25
Precision medicine,Health care
Patent: 5
26
Bliss Biopharmaceutical (Hangzhou) Co., Ltd.
Patent: 5
27
Nanjing Blue Shield Biotech Co., Ltd.
Patent: 4
28
Patent: 4
29
Patent: 4
30
RegeneCore Biotech Co., Ltd
Patent: 4
31
Patent: 4
32
Patent: 4
33
Patent: 4
34
Patent: 4
35
Adult education,Pinyin,Architecture,
...[+2]
Patent: 4
36
Patent: 4
37
Cell therapy,Health care
Patent: 4
38
Hangzhou Biolynx Technology Co. Ltd.
Patent: 4
39
Patent: 4
40
Patent: 4
41
Patent: 3
42
Beijing Luzhu Biopharmaceutical Co., Ltd.
Patent: 3
43
Patent: 3
44
Patent: 3
45
Patent: 3
46
Patent: 3
47
Medicine,In vitro,Hepatitis test,
...[+2]
Patent: 3
48
Patent: 3
49
Pinyin,Literature,Public university,
...[+2]
Patent: 3
50
Computer science,Artificial intelligence,Vocational education,
...[+2]
Patent: 3
Page generation time: Jul 18 2025